Description
Pomalidomide is a potent immunomodulatory agent used primarily to treat multiple myeloma in patients unresponsive to prior therapies. It inhibits cancer cell growth, modulates the immune response, and reduces inflammation, often combined with dexamethasone for enhanced efficacy in relapsed or refractory cases.